beta

MTFB

Motif Bio Plc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.

Market Cap: 2.67 Million

Primary Exchange: NASDAQ

Website: https://www.motifbio.com/

Shares Outstanding: 24.3 Million

Float:

Dividend: (%)

Beta: 0.328697307812375

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 769 trading days

From: 2017-10-06 To: 2019-12-13

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud